Biosimilar development requires extensive analytical, preclinical, and clinical characterization to demonstrate similarity to the reference product, a process that typically takes 5-8 years and costs $100-300 million
Other common side effects include: Dizziness and lightheadedness, particularly during the first few weeks Fatigue and low energy , often related to reduced caloric intake Headaches , which typically resolve within the first month Sulfur burps , a distinctive and common complaint Diarrhea , which usually resolves as the body adjusts Injection site reactions including redness and mild swelling Less common but important considerations Some patients experience hair loss on GLP-1 medications
Neuroscience 82:12131223 Dringen R, Kranich O, Hamprecht B (1997) The -glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture
Truveta Data allows researchers to study trends in treatment access, outcomes, and safety in this demographic, which is often underrepresented in clinical trials